CCF Facebook LIVE Announcement Lunch with Experts Heloisa P. Soares, MD, PhD Sept 3

Heloisa Soares, MD, PhD

Medical Oncologist, NET Program at the Huntsman Cancer Institute (HCI) at the University of Utah

Co-Physician Leader, GI Clinical Trials Research Group

Assistant Professor at HCI


NANETS 2020 Grant Recipient

Congratulations to Dr. Soares upon receiving the NANETS 2020 Theranostics Investigator Scholarship (NTIG) award! The NTIG is intended to push forward the boundaries of molecularly targeted radionuclide therapy and diagnostics for patients with neuroendocrine tumors.

Dr. Soares received the scholarship for her proposal, “The Role of HDAC Inhibitors in Combination to PRRT in NET Xenografts.” She will be mentored by Kathryn Morton, MD, Professor of Radiology at the University of Utah.

NTIG is made possible by the support of Advanced Accelerator Applications (AAA), a long-time supporter of NANETS’ educational events and research. NTIG is a two-year, $100,000 award. The NANETS Scientific Review & Research Committee establishes the award criteria, reviews process, and independently selects the recipient.

To read more about the 2020 and previous awards, click here:




National Comprehensive Cancer Network (NCCN)

Dr. Heloisa Soares is a member of the NCCN Guidelines Panel for Neuroendocrine Tumors. Click here for the NCCN Clinical Practice Guidelines in Oncology, Neuroendocrine and Adrenal Tumors, Version 2.2020, July 2020. You will need to register for a free account to access these guidelines.

NCCN Guidelines for Patients®, patient-friendly translations of the NCCN Guidelines®, are meant to help patients with cancer talk with their physicians about the best treatment options for their disease.

The NCCN Patient Guideline “Library” consists of 39 Guidelines and additional Quick Guides—one to two page summaries of the full guideline—that individuals can view, download, and print free of charge on

Here is a link to the Neuroendocrine Tumor Guidelines for Patients:


Social Media:
Twitter, @helops79,

Print Friendly, PDF & Email